Skip to main content
. 2011 May-Jun;43(3):306–310. doi: 10.4103/0253-7613.81513

Table 2.

Outcome of the study on oral and SL misoprostol for uterine evaluation following early fetal demise

graphic file with name IJPharm-43-306-g002.jpg